[Choice of surgical procedure in esophageal cancer].
In a retrospective study results of surgical treatment of esophageal cancer by transthoracic and abdominal transhiatal approach are compared with each other. 70% of the patients (n = 21) had tumor stage III. The overall 30-day-lethality is 9.5%, being identical for the transthoracic (n = 10) and the transhiatal (n = 11) group with 10% and 9%, respectively. The frequency of postoperative, mainly pulmonary complications is equally distributed. The cumulative 3-years-survival-rate is 19%. However, a considerable difference among both approaches is obvious being 30% for group I and only 9% for group II.
Röher
H D
HD
Abteilung für Allgemeine und Unfallchirurgie, Zentrum für Operative Medizin I, Universität Düsseldorf.
Linn
R M
RM
Stahlknecht
C D
CD
Thon
K
K
D000230:Adenocarcinoma / Q000601:surgery*; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D002423:Cause of Death; D004938:Esophageal Neoplasms / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007889:Leiomyoma / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011183:Postoperative Complications / Q000401:mortality*; D012307:Risk Factors; D013908:Thoracotomy
Zur operativen Verfahrenswahl beim Oesophaguscarcinom.